Evolution of clinical outcomes following hepatitis C virus clearance
10.3760/cma.j.cn501113-20221110-00557
- VernacularTitle:丙型肝炎病毒清除后的临床结局演变
- Author:
Jia YANG
1
;
Huiying RAO
Author Information
1. 北京大学人民医院 北京大学肝病研究所 丙型肝炎和肝病免疫治疗北京市重点实验室，北京 100044
- Keywords:
Hepatitis C;
Direct-acting antivirals;
Hepatocellular carcinoma;
Portal hypertension
- From:
Chinese Journal of Hepatology
2022;30(11):1137-1143
- CountryChina
- Language:Chinese
-
Abstract:
As hepatitis C treatment entered the era of direct-acting antiviral drugs, an increasing number of patients received treatment and achieved virus clearance, but virus clearance is merely a relative endpoint. Future emphasis will be placed on post-treatment benefits and the evolution of clinical outcomes. This article aims to describe the improvement in all-cause mortality and hepatic and extrahepatic-related diseases following virus clearance, particularly in patients treated with direct-acting antiviral drugs.
